Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice.

ABSTRACT:

Background

The association of gadolinium-based contrast agents (GBCAs) with nephrogenic systemic fibrosis (NSF) has led to a heightened awareness towards patients' renal function. Whereas detailed guidelines exist for the use of GBCAs in adult patients, best practice is less well defined in children, especially in the very young. We aimed at identifying current practice with regards to the use of GBCAs in children who undergo cardiovascular magnetic resonance.

Methods

We conducted a worldwide survey among cardiac imagers with pediatric expertise. The questionnaire contained 21 questions covering the imagers' work environments, GBCAs used, monitoring of renal function, and a special emphasis was placed on the practice in neonates.

Results

The survey yielded 70 replies.

SUBMITTER: Meng H 

PROVIDER: S-EPMC3492017 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature